IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management V, LLC

Q4 2021 Holdings

Filed 2022-02-11 | 16 holdings | $78.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.(ACRS)COM00461U105$18.3M1,258,24323.3%
Cullinan Oncology, Inc.(CGEM)COM230031106$17.6M1,143,00622.5%
Cue Health Inc.(HLTHQ)COM229790100$15.7M1,167,78219.9%
Compass Therapeutics, Inc.(CMPX)COM20454B104$13.9M4,400,00017.8%
Adagio Therapeutics, Inc.(IVVD)COM00534A102$12.7M1,745,06016.1%
Pardes Biosciences IncCOM69945Q105$153.9K9,400,5150.2%
Somalogic, Inc.(SLGCUSD)COM CL A83444K105$62.0K5,326,4720.1%
TheseusPharmaceuticals, Inc.COM88369M101$40.7K3,212,7320.1%
Quantum-Si Incorporated(QSI)COM CL A74765K105$18.4K2,342,0610.0%
Kinnate Biopharma Inc.COM49705R105$15.5K875,0010.0%
Adicet Bio, Inc.(TORCEUR)COM007002108$11.9K680,0000.0%
Hims & Hers Health, Inc.(HIMS)COM CL A433000106$11.2K1,706,9220.0%
Gemini Therapeutics, Inc.COM36870G105$7.1K2,435,1250.0%
Research Alliance Corp. IICOM CL A760873109$4.9K500,0000.0%
23andMe Holding Co.COM CL A90138Q108$2.7K406,9130.0%
Pharvaris N.V.(PHVS)COMN69605108$49134,1420.0%